Compare Enveric Biosciences Inc (ENVB) vs TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock (TTWO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock — how do they compare? Enveric Biosciences Inc trades at $1.58 (market cap $6.20M), while TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock trades at $243.72 (market cap $46.84B). The key difference: TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock is far larger — about 7554.8× Enveric Biosciences Inc's market cap, and TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | TTWO | |
|---|---|---|
Market Cap | $6.20M | $46.84B |
Sector | Health | Media |
52-Week High | $17.40 | $262.29 |
52-Week Low | $1.27 | $189.69 |
Enterprise Value | $1.30M | $47.96B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.56, up 1.3% on the day, with a bullish technical signal from moving averages and strong analyst support (75% buy ratings). The company reported four consecutive quarterly earnings beats in 2025, including a positive EPS of $0.85 in Q4, while recent news highlights progress in preclinical studies for its non-hallucinogenic psychiatric drug candidate EB-003.
Despite operational losses and negative ROE/ROA, ENVB's consistent earnings surprises and advancing pipeline present speculative growth potential. Key risks include cash burn, clinical trial outcomes, and regulatory hurdles, requiring careful risk assessment by investors.
Take-Two Interactive (TTWO) trades at $244.33, down 3.64% today, with a bullish technical outlook supported by moving averages and strong analyst consensus. Recent Q1 2026 earnings beat expectations, driven by NBA 2K and Grand Theft Auto performance, while the company maintains focus on the upcoming GTA VI launch in November 2026. Fundamentals show revenue growth to $5.63B in 2025, but net losses persist, with a negative net income margin of -4.79%.
The stock's upside potential is tied to GTA VI's success, with a consensus price target of $300.55 offering 23% upside. Key risks include execution on the high-stakes game launch, sustained profitability challenges, and competitive pressures in the gaming industry. Investor sentiment remains optimistic due to the blockbuster title's preorder momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock
Found in 1993, Take-Two consists of three wholly owned labels, Rockstar Games, 2K, and Zynga. The firm is one of the world's largest independent video game publishers on consoles, PCs, smartphones, and tablets. Take-Two's franchise portfolio is headlined by Grand Theft Auto (345 million units sold) and contains other well-known titles such as NBA 2K, Civilization, Borderlands, Bioshock, and Xcom. Zynga mobile titles include Farmville, Empires & Puzzles, and CSR Racing.
Read more on TTWO →
